Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
IV Magnesium Sulfate vs Terbutaline in Pediatric Acute Asthma
NCT06626620Phase 3Completed
- Start
- Jan 2024
- Primary completion
- Sep 2024
- Modality
- Small Molecules
- Countries
- 1
01
Overview
Phase 3, randomised trial in asthma comparing IV Magnesium Sulfate with IV Terbutaline (2 arms). Primary endpoint: Peak Expiratory Flow Rate at 4 hours. Started Jan 2024; status: completed.
02
Drugs
magnesium sulfateterbutaline
03
Conditions
asthma
Beyond the preview
Go deeper on NCT06626620.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT06626620.